Blog

Explore how the 2023 Nobel Prize discovery of nucleoside modifications advanced mRNA therapeutics, from IVT mRNA design to LNP delivery and preclinical development.

Explore how AI-driven drug discovery (AIDD) is transforming drug design, from AlphaFold2 and computational protein design to AI antibody engineering and experimental validation.

Learn how 5′ UTR engineering can optimize mRNA translation in T cells, reduce tonic signaling, and improve CAR-T cell therapy performance.

Learn how next-generation sequencing (NGS) works step by step, from sample preparation and library preparation to sequencing, FASTQ data, bioinformatics, and biological interpretation.

Learn about LNP formulation and mRNA encapsulation, including lipid selection, payload scale, QC, particle size, encapsulation efficiency, and service options.

Learn what next-generation sequencing (NGS) is, how NGS works, common applications, NGS vs. Sanger, sequencing strategies, and how to plan an NGS project.

Explore custom IVT mRNA synthesis, including workflow, service grades, purification, capping, modified nucleotides, Poly(A) tails, QC and project timelines.

Learn how to choose the right DNA sequencing service based on your research goals, read length, accuracy, turnaround time, cost, and data requirements. Compare Sanger, NGS, and Nanopore sequencing.

Whole plasmid sequencing, powered by Nanopore Technology. Complete end-to-end plasmid validation, beyond sanger & short-read NGS

From intelligent molecular design to experimental validation, AI is reshaping how the next generation of antibody therapeutics is discovered, optimized, and developed.